TriangleDISEASE & TREATMENT SETTING
Testicular Cancer
Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.
Exact scope
Testicular Cancer
- Source population
- Not part of this definition
- Disease extent
- Not part of this definition
- Treatment line
- Not part of this definition
- Stage
- Not part of this definition
- Resectability
- Not part of this definition
Biomarkers, prior therapy and derivation
- molecular
- prior therapy
- derivation status
- unresolved
- derivation note
- Derived from NCI topic(s): Testicular Cancer. Strongest NCIt resolution: ambiguous. Entity-level scope; stage, biomarker and treatment line are not yet part of this definition.
- source wording
- Source null
9 more-specific settings
IFEX: Testicular Cancer (third-line-or-later) →IFOSFAMIDE: Testicular Cancer (third-line-or-later) →Avopef: refractory Testicular Cancer →Cisplatin: advanced Testicular Cancer →Stage 0 Testicular Cancer →Stage I Testicular Cancer →Stage II Testicular Cancer →Stage III Testicular Cancer →recurrent Testicular Cancer →
Study evidence for this setting
Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant
High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors
Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors
Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors
Engagement of Patients With Advanced Cancer
Source relationships and population-mapping limitations
- bindings
- release id
- clinical-indications-draft-1
- disease state id
- ds-testicular-cancer
- binding id
- ncit-C7251
- source collection
- ncit-concept
- source key
- C7251
- source excerpt
- Source null
- match status
- ambiguous
- match note
- Resolution status: ambiguous.
- recorded at
- 2026-09-10T00:00:00Z
- release id
- clinical-indications-draft-1
- disease state id
- ds-testicular-cancer
- binding id
- ncit-C9063
- source collection
- ncit-concept
- source key
- C9063
- source excerpt
- Source null
- match status
- ambiguous
- match note
- Resolution status: ambiguous.
- recorded at
- 2026-09-10T00:00:00Z
- mappings
Download this complete draft source relationship record →
Preserved source evidence · Not medical advice